<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37170571</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-2300</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of international medical research</Title><ISOAbbreviation>J Int Med Res</ISOAbbreviation></Journal><ArticleTitle>Factors associated with oxygen requirement and persistent symptoms 1 year after severe COVID-19 infection.</ArticleTitle><Pagination><StartPage>3000605231173317</StartPage><MedlinePgn>3000605231173317</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">03000605231173317</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/03000605231173317</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to describe the prevalence and factors associated with the need for supplemental oxygen and persistent symptoms 1 year after severe SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this historical cohort and nested case-control study, we included adults with severe COVID-19 (requiring admission to the intensive care unit or invasive mechanical ventilation). We evaluated factors associated with a need for supplemental oxygen and persistent symptoms 1 year after severe infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 135 patients (median age 62 years, 30% women). At 1-year follow-up, the main symptoms were dyspnea (32%), myalgia (9%), cough (7%), anxiety (4%), and depression (5%); 12.59% of patients had prolonged requirement for supplemental oxygen. Factors associated with a persistent requirement for supplemental oxygen were female sex (odds ratio 3.15, 95% confidence interval 1.11-8.90) and Charlson Comorbidity Index&#x2009;&gt;&#x2009;4 (odds ratio 1.60, 95% confidence interval 1.20-2.12).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found that a high prevalence of supplemental oxygen requirement 1 year after severe COVID infection was associated with female sex and a baseline high rate of comorbidities. It is unknown whether this prevalence was related to other factors, such as the altitude at which patients lived. More than half of patients had prolonged post-COVID syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serrano</LastName><ForeName>Mar&#xed;a Natalia</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation><Identifier Source="RINGGOLD">27964</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Oscar Mauricio</ForeName><Initials>OM</Initials><Identifier Source="ORCID">0000-0001-5401-0018</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation><Identifier Source="RINGGOLD">27964</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario San Ignacio, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rueda</LastName><ForeName>Camilo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5209-8992</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation><Identifier Source="RINGGOLD">27964</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arboleda</LastName><ForeName>Alejandra Ca&#xf1;as-</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation><Identifier Source="RINGGOLD">27964</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario San Ignacio, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botero</LastName><ForeName>Juan David</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-6925-3570</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation><Identifier Source="RINGGOLD">27964</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bustos</LastName><ForeName>Marlon Mauricio</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation><Identifier Source="RINGGOLD">27964</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario San Ignacio, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Int Med Res</MedlineTA><NlmUniqueID>0346411</NlmUniqueID><ISSNLinking>0300-0605</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">oxygen requirement</Keyword><Keyword MajorTopicYN="N">persistent symptom</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">supplemental oxygen</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>3</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37170571</ArticleId><ArticleId IdType="pmc">PMC10184210</ArticleId><ArticleId IdType="doi">10.1177/03000605231173317</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Salian VS, Wright JA, Vedell PT, et al.. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Mol Pharm 2021; 18: 754&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464914</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. Vaccination Data. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Yong SJ.Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021; 53: 737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Guijarro C, Plaza-Canteli S, et al.. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study. Lung 2021; 199: 249&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, et al.. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens 2022; 11: 269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG.Research electronic data capture (REDCap) &#x2013; A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo Marin B, Aghagoli G, Lavine K, et al.. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021; 31: 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh V, Arroliga AC, Bourgeois JA, et al.. Post-acute sequelae of COVID-19 in adults referred to COVID recovery clinic services in an integrated health system in Texas. Proc (Bayl Univ Med Cent) 2021; 34: 645&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545149</ArticleId><ArticleId IdType="pubmed">34732978</ArticleId></ArticleIdList></Reference><Reference><Citation>Loerinc LB, Scheel AM, Evans ST, et al.. Discharge characteristics and care transitions of hospitalized patients with COVID-19. Healthc (Amst) 2021; 9: 512&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836258</ArticleId><ArticleId IdType="pubmed">33383393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul M, Gupta P, Kalra S, et al.. New domiciliary supplemental oxygen therapy after hospitalisation for COVID-19 in metropolitan Chicago. ERJ Open Res 2022; 8: 00577&#x2013;02021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8883040</ArticleId><ArticleId IdType="pubmed">35345420</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, et al.. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med 2021; 174: 576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al.. Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability. Respiration 2022; 101: 132&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8678253</ArticleId><ArticleId IdType="pubmed">34569550</ArticleId></ArticleIdList></Reference><Reference><Citation>Comelli A, Viero G, Bettini G, et al.. Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study. Front Med (Lausanne) 2022; 9: 834354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8981315</ArticleId><ArticleId IdType="pubmed">35391879</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022; 10: 761&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K, Montenegro-Jim&#xe9;nez Y, Torres-Castro R, et al.. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chron Respir Dis 2021; 18: 14799731211002240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzo G, Ronzoni L, Campo G, et al.. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study. BMC Pulm Med 2022; 22: 408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9643983</ArticleId><ArticleId IdType="pubmed">36352423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et al.. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun 2020; 89: 594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al.. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8: 416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam N, Madathil S, Tahani N, et al.. Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clin Infect Dis 2022; 74: 301&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135551</ArticleId><ArticleId IdType="pubmed">33893486</ArticleId></ArticleIdList></Reference><Reference><Citation>Deana C, Vetrugno L, Cortegiani A, et al.. Clinical Medicine Quality of Life in COVID-Related ARDS Patients One Year after Intensive Care Discharge (Odissea Study): A Multicenter Observational Study. J Clin Med 2023; 12: 1058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918008</ArticleId><ArticleId IdType="pubmed">36769705</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo RF, Mondoni M, Parazzini EM, et al.. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J 2021; 58: 2100870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G, Yadav S, Kumar R.Post-intensive Care Syndrome: an Overview. J Transl Int Med 2017; 5: 90&#x2013;92. doi: 10.1515/jtim-2016-0016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>